Nuvation Bio
Price & Volume
Stats
See more52W Range | $1.54-$4.08 |
Market Cap | $1.2B |
Shares Short | 68M |
Financials
See moreRevenue (12 Mos) | $14.3M |
Revenue Growth (YoY) | 236.8% |
Gross Profit (12 Mos) | $3.9M |
Diluted EPS | -$0.38 |
News
See moreYahoo Finance • 2 months ago
Nuvation Bio Inc (NYSE:NUVB) Reports Mixed Q2 2025 Results with Strong Revenue Beat but Cautious Market Reaction
Yahoo Finance • 3 months ago
Nuvation Bio's SWOT analysis: IBTROZI approval boosts stock prospects
Yahoo Finance • 4 months ago
Nuvation Bio price target lowered to $6 from $10 at RBC Capital
Yahoo Finance • 4 months ago
Nuvation Bio's SWOT analysis: FDA approval boosts stock prospects
About
CEO | Dr. David T. Hung M.D. |
CFO | Mr. Philippe Pierre Sauvage |
Address | 1500 Broadway, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 278 |
